identify a putative metabolic effect of b -AR in DCM that may be deleterious.
Introduction
aspects of cardiac function including inotropy, chronotropy, coronary blood flow and metabolic substrate preferCatecholamine stimulation is considered deleterious in ence. While the b-adrenergic effects of catecholamines on congestive heart failure (CHF). It has been suggested that heart rate and contractility are known to be desensitized the myocardial O requirements associated with catechol- [4] [5] [6] , less is known regarding the effects on coronary 2 amine stimulation in CHF are excessive and that catecholblood flow, O utilization, and substrate preference. The 2 amine administration is associated with altered myocardial extent to which different adrenergic receptor subtypes energetics in CHF [1] [2] [3] . Catecholamines modulate several (b ,b , or a) mediate these effects is also incompletely adrenergic antagonists in patients with CHF [7] [8] [9] [10] , in stabilization period following deactivation of the pacecontrast to the adverse outcomes demonstrated with the maker preceded all experiments in DCM. chronic use of adrenergic agonists [11] [12] [13] [14] . It appears that Animals used in this study were maintained in accorddifferent b-adrenergic antagonists with varying degrees of ance with the Guide for the Care and Use of Laboratory selectivity exert similar salutary effects, independent of Animal Resources [DHHS Publication No (NIH) 86-23, their ability to restore the downregulated and desensitized
Revised 1996] and the guidelines of the Institutional b -adrenergic receptors [15] [16] [17] [18] [19] . This raises the possibility Animal Care and Use Committee at Allegheny General 1 that metabolic derangements may contribute to the toxic Hospital. effects of catecholamines in CHF. It is conceivable that Systemic hemodynamics, LV dP/dt, CO and CBF some or all of adrenergic receptor subtypes may be measurements and aortic (Ao) and coronary sinus (Cs) implicated in such mechanisms.
blood samples were obtained at rest and in response to The current study was designed to determine the effects graded infusions of norepinephrine (0.05-0.4 mg/kg per of cardiac stimulation with exogenously administered min), dobutamine (1-10 mg / kg per min), phenylephrine catecholamines with different affinity for the b , b , and a (1-5 mg / kg per min) and isoproterenol (0.05-0.4 mg / kg 1 2 adrenergic receptors on coronary blood flow, myocardial per min). A 30-min period of stabilization between drug O utilization, and metabolic substrate utilization in coninfusions allowed all parameters to return to baseline. The 2 scious dogs with pacing induced dilated cardiomyopathy agonists were infused in random order, in each dog. (DCM), compared to the responses elicited in the same Phenylephrine infusion was always performed on a sepaanimals studied in the control state.
rate day due to its prolonged effects on hemodynamics. halothane (1% vol). Using a sterile technique, catheters heart rate responses to catecholamines under the two were implanted in the descending thoracic aorta (Ao), left different experimental conditions. atrium (LA), right atrium (RA) and coronary sinus (Cs)
Myocardial stroke work (SW) was calculated using the through an incision in the left fifth intercostal space. A formula SW5DP3DV 30.0136, where DP5LVP2LVEDP solid-state pressure transducer was implanted in the left and DV5LVEDV2LVESV, using sonomicrometry-derived ventricular (LV) apex to measure LV pressures and LV data [22] [23] [24] . The MvO was then normalized for SW 2 5 dP/dt. Ultrasonic Doppler flow probes were implanted in (M O 310 / SW) as an index of contractile efficiency for v 2 the ascending aorta and the left circumflex coronary artery, each agonist in control and in DCM. for determination of cardiac output (CO) and coronary blood flow (CBF), respectively. Piezoelectric ultrasonic 2.1. Myocardial acid-base balance and respiratory dimension crystals were implanted on the anterior and quotient calculation posterior endocardial surfaces of the LV to measure the internal short axis diameter in end-diastole (LVEDD) and Blood samples from the coronary sinus (Cs) were end-systole (LVESD). Similar piezoelectric crystals on the analyzed and the coronary sinus pH (Cs-pH) was plotted in endocardial and epicardial surfaces of the posterior wall response to the different catecholamine infusions. This was were utilized to measure wall thickening (WTh). A suturerepeated in control and DCM animals and was utilized as a less pacing lead was implanted on the epicardial surface of measure of myocardial acidosis. Table 1 illustrates the hemodynamic perturbations seen in association with the development of advanced DCM. Myocardial b-adrenergic receptors (b-AR) were meaAdvanced DCM was characterized by increased heart rate, sured on crude sarcolemmal membrane preparations from left ventricular end-diastolic and end-systolic dimensions eight animals in advanced DCM and were compared to (LVEDD, LVESD) and decreased LV systolic (LVP) and similar membrane preparations from normal dogs (n53).
Myocardial b-adrenergic receptors
aortic mean pressure, regional wall thickening (WTh), We performed receptor antagonist binding studies using fractional shortening (FS), ejection fraction (EF) and 125 125
I-cyanopindolol ( I-CYP) to determine total b-AR stroke work (SW). The sinus tachycardia was responsible density, as well as competitive inhibition agonist binding for maintaining cardiac output (CO) while stroke volume studies using graded concentrations of isoproterenol to (SV) was reduced significantly. CBF / beat was lower in determine receptor affinity, as described by Kiuchi et norepinephrine Statistical significance was determined using repeated measures ANOVA for comparisons between multiple Table 2 illustrates the peak responses to IV norepinephgroups or the two-tail Student's t-test (two-sample t-test rine infusion (0.4 mg / kg per min). Severe DCM was assuming unequal variances) for comparisons between two associated with depressed peak contractile responses to groups. A P value of ,0.05 was considered significant. norepinephrine (15365.1 vs. 8567.5%, P,0.001), and a (Fig. 4) shift toward glycolysis. In contrast, isoproterenol signifiwas observed with isoproterenol alone (ISO) in either cantly lowered the RQ in the dogs with DCM to values control or advanced DCM animals. Coronary sinus pH was similar to those seen in the control group (ISO: 0.6760.06, preserved (7.3760.01 to 7.3860.07), as well. Myocardial P,0.02 compared to RQ in DCM). These findings (Fig. 7) RQ (Fig. 7) decreased to control levels in the ISO1MET suggest that b-AR stimulation in DCM shifts metabolic group (0.8860.05 to 0.6660.07, P,0.01). This was presence of metoprolol were blunted in dogs with DCM. compared to controls. Decreased total receptor density However, combined isoproterenol and metoprolol adminis-(137624 vs. 82610 fmol / mg protein) as well as a compared to controls. This was accompanied by a relative induced DCM compared to the same animals in control increase in both density and affinity, of b-ARs, that state. This was accompanied by an increased preference for 2 constituted a higher proportion of the total b-ARs in the glycolytic substrates (↑RQ) and a decrease in Cs-pH, failing as opposed to the normal myocardium (control vs. compared to controls. DCM: 4068 vs. 6264%).
Conventionally, FFA are the preferred metabolic substrate for normal myocardium. However, in states of stress such as heart failure, glycolysis has been demonstrated to assume a greater role in ATP synthesis [25, 31] . The reason 4. Discussion involves the greater efficiency of glycolysis in terms of ATP generated per mole O consumed. We observed an 1 [4, 5, [27] [28] [29] [30] . However, it was also apparent that the In contrast, combined b / b stimulation with iso- 1 2 desensitized contractile response (LV dP/dt) to exogenousproterenol caused a similar impairment in contractile and ly administered b-or a-(dobutamine, norepinephrine) chronotropic response, but a different metabolic pattern, (and CVR response was enhanced) in response to As it has been described in both human myocardial phenylephrine, signifying a potentially enhanced a-vastissue biopsies [32, 33] and pacing-induced DCM in dogs, there is down-regulation of b -AR with preservation or evident by the lack of significant decline in CBF during 1 up-regulation b -AR in CHF (Fig. 8) conflicting results [36, 37] . Notably, over-expression has the opposite direction of what was observed in our been at many fold higher levels than observed in human or experiments [44, 45] . Therefore, the observed limitation in mammalian models of CHF. Data from these transgenic O utilization in response to b and a-AR stimulation is 2 1 murine models suggest that while b -AR over-expression unlikely to be a shift in hemoglobin affinity.
1 may lead to deleterious myocardial sequelae, this may not In our study, we did not take into account the potential be true for b -AR, where an 'optimal range' of b -AR effect of isoproterenol on b-adrenergic receptors. While It has been hypothesized that the increased energy effects in different species has also been studied by Shen et demands of the failing myocardium lead to a state of al. [47] . This study demonstrated a more pronounced effect relative energy depletion, through an initial compensatory on both systemic hemodynamics and FFA utilization in phase of increased O extraction [1, 38] . This paradigm dogs, compared to rats or non-human primates. However 2 [39] suggests that further inotropic stimulation would the b-AR specific agonists BRL37344 and CL316243, 3 impose further energy demands and ultimately accelerate rather than isoproterenol were used in this study of normal myocardial cell death. Investigators have attempted to dogs. Since neither of these studies has investigated the confirm or refute it, utilizing a variety of in-vitro and function of b-ARs in the failing heart, a theoretical 3 in-vivo models. The heterogeneity of those models and up-regulation of these receptors or enhanced affinity of methods to investigate M O has led to conflicting results.
isoproterenol for them in dilated cardiomyopathy, contriv 2
Our study attempted to minimize these variables by buting to increased FFA oxidation cannot be entirely investigating a well-validated model of end-stage dilated excluded. cardiomyopathy, with no evidence of hypertrophy or
In conclusion, advanced DCM in our model was associmyocardial ischemia, in the conscious state. To normalize ated with impaired inotropic responses to catecholamines. for differences in heart rate that accompany the pro-
The impairment in contractile responses to dobutamine and gression of dilated cardiomyopathy, we expressed O norepinephrine in DCM was associated with limitations in 2 indices on a 'per-beat' basis. O utilization, and a metabolic shift toward myocardial 2 Our findings suggest a parallel impairment in contractile anaerobic glycolysis and myocardial acidemia. performance and myocardial oxygen consumption in reIn the presence of combined b / b stimulation with 1 2 sponse to inotropic stimulation in end-stage carisoproterenol, however, there was a similar impairment in diomyopathy. Catecholamine mediated increases in glycontractile response, but a different metabolic pattern, with colytic flux subtended by a and b receptor subtype leads a shift toward FFA oxidation (decreased RQ, increased 1 1 to reduced MvO due to the greater efficiency of glucose myocardial FFA extraction), preserved O utilization 2 2 oxidation. This is reflected in less O extracted. However, (MvO / beat, ability to augment MvO / SW) and (a-v)O demanding process of FFA oxidation is deleterious in the Myocardial ischemia was not present in our studies, as long term, remains to be examined.
